Somer Bishop is a clinical psychologist and professor in residence of psychiatry at the University of California, San Francisco.
Somer Bishop
Assistant professor
University of California, San Francisco
From this contributor
Rethinking autism assessments in the time of COVID-19: Q&A with Bishop, Zwaigenbaum
Moving most clinical assessments online during the coronavirus pandemic has created a digital divide while closing some geographical ones, say Somer Bishop and Lonnie Zwaigenbaum.
Rethinking autism assessments in the time of COVID-19: Q&A with Bishop, Zwaigenbaum
Questions for Bishop, Havdahl: Tantrums trick autism tests
Children with low intelligence or behavioral issues — but not autism — may meet the criteria for autism on standard diagnostic tests.
Questions for Bishop, Havdahl: Tantrums trick autism tests
Seeking precise portraits of girls with autism
Researchers need to consider new ways of capturing how autism manifests in girls, who may find clever ways of camouflaging their symptoms.
Gauging intelligence in autism over time
Adapting traditional tests of intelligence for people with intellectual disability can deflate their scores over time. Somer Bishop calls for tests that more accurately assess intelligence in this group.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.